Lumican modulates adipocyte function in obesity-associated type 2 diabetes

Obesity-associated type 2 diabetes (DM) leads to adipose tissue dysfunction. Lumican is a proteoglycan implicated in obesity, insulin resistance (IR), and adipocyte dysfunction. Using human visceral adipose tissue (VAT) from subjects with and without DM, we studied lumican effects on adipocyte funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Strieder-Barboza, Flesher, Carmen G., Geletka, Lynn M., Eichler, Tad, Akinleye, Olukemi, Ky, Alexander, Ehlers, Anne P., Lumeng, Carey N., O’Rourke, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728465/
https://www.ncbi.nlm.nih.gov/pubmed/36457256
http://dx.doi.org/10.1080/21623945.2022.2154112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728465/
https://www.ncbi.nlm.nih.gov/pubmed/36457256
http://dx.doi.org/10.1080/21623945.2022.2154112

Ejemplares similares